Approximately 3–5% of NSCLC tumors harbor rearrangements of the anaplastic lymphoma kinase (ALK) gene, which defines a distinct molecular subtype primarily associated with adenocarcinoma histology. Here, ALK is linked to non-small cell lung carcinoma.